Skip to main content
. 2019 May 16;25:3617–3623. doi: 10.12659/MSM.914295

Figure 1.

Figure 1

Acute treatment with doxorubicin induced HeLa cells senescence at a low efficiency. (A) Dose-survival curve of HeLa cells to doxorubicin treatment for 3 days. (B–F) SA-β-Gal staining of HeLa cells treated by doxorubicin for 3 days at 0, 0.05, 0.1, 0.2, or 0.4 μg/ml, respectively.